Skip to main content

Advertisement

Log in

Ethanolgel sclerotherapy of venous malformations improves health-related quality-of-life in adults and children – results of a prospective study

  • Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To assess the treatment-induced changes of health-related quality-of-life (HRQoL) in patients with venous malformations (VM) who underwent ethanol gel sclerotherapy.

Methods

The prospective study in children and adults was approved by the local ethics committee. 31 patients (mean age 23.42 years, range 6.6 – 46.5; 26 female, 5 male) with VM were included. Patients’ self-assessed HRQoL was measured before and after treatment using psychometrically validated questionnaires for adults and children. Differences were analysed with a paired t test.

Results

58 sclerotherapy sessions were performed. The Physical Component Summary (PCS) at baseline was 43.69 and increased significantly (p = 0.01122) to 48.95 after treatment. The bodily pain (BP) scale increased significantly from 37.94 to 48.56 (p = 0.00002), the general health (GH) scale increased significantly from 46.69 to 52.17 (p = 0.00609). Baseline Physical Summary Score (PHS) in children increased significantly after treatment (p < 0.00001) from 25.25 to 45.89. The baseline Psychosocial Summary Score (PSS) in children was 51.08 and increased significantly (p = 0.00031) after treatment to 58.84.

Conclusion

Paediatric and adult patients with VM suffer from bodily pain with overall reduced physical functioning. After sclerotherapy, these restrictions are successfully returning to normal levels with a positive effect on mental and psychosocial domains.

Key points

Sclerotherapy in venous malformation patients has an unknown effect on health-related quality-of-life

Prospective study showed improvements in bodily pain and general health in adults

Children and adults improved from treatment with ethanol gel

Sclerotherapy is an appropriate therapy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A et al (2015) Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 136:e203–e214

  2. Vogel SA, Hess CP, Dowd CF, Hoffman WY, Kane AJ, Rajaii R et al (2013) Early versus later presentations of venous malformations: where and why? Pediatr Dermatol 30:534–540

  3. Lee BB, Baumgartner I, Berlien P, Bianchini G, Burrows P, Gloviczki P et al (2015) Diagnosis and treatment of venous malformations. Consensus document of the International Union of Phlebology (IUP): updated 2013. Int Angiol 34:97–149

  4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45:S5–S67

  5. Schumacher M, Dupuy P, Bartoli JM, Ernemann U, Herbreteau D, Ghienne C et al (2011) Treatment of venous malformations: first experience with a new sclerosing agent–a multicenter study. Eur J Radiol 80:e366–e372

  6. Sannier K, Dompmartin A, Théron J, Labbé D, Barrellier MT, Leroyer R et al (2004) A new sclerosing agent in the treatment of venous malformations. study on 23 cases. Interv Neuroradiol 10:113–127

  7. Saris-Baglama RN, Dewey CJ, Chisholm GB, Plumb E, King J, Rasicot P et al (2011) Quality metric health outcomes scoring software 4.5 – users guide. Quality Metric Inc. Lincoln

  8. Ware JE Jr, Kosinski M, Dewey JE (2000) How to score version 2 of the SF-36® Health Survey. QualityMetric Inc, Lincoln

    Google Scholar 

  9. Landgraf JM, Abetz L, Ware JE (1996) The CHQ: a user's manual, 1st edn. The Health Institute, Boston

    Google Scholar 

  10. Taft C, Karlsson J, Sullivan M (2001) Do SF-36® summary component scores accurately summarize subscale scores? Qual Life Res 10:395–404

    Article  CAS  PubMed  Google Scholar 

  11. Balakrishnan K, Bauman N, Chun RH, Darrow DH, Grimmer JF, Perkins JA et al (2015) Standardized outcome and reporting measures in pediatric head and neck lymphatic malformations. Otolaryngol Head Neck Surg 152:948–953

  12. Burrows PE, Mason KP (2004) Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 15:431–445

    Article  PubMed  Google Scholar 

  13. Weinstein JM, Chamlin SL (2005) Quality of life in vascular anomalies. Lymphat Res Biol 8:256–260

    Article  Google Scholar 

  14. Van der Pleog HM, van der Ploeg MN, van der Ploeg-Stapert JD (1995) Psychological aspects of the Klippel-Trenaunay syndrome. J Psychosom Res 39:183–191

    Article  Google Scholar 

  15. Boetes C, Boll AP, Hartman PH, van Oostrom CG, Rieu PN, de Rooij M et al (1997) Klippel-Trenaunay-type congenital angiodysplasia syndrome; medical and psychological aspects. Ned Tijdschr Geneeskd 141:650–651

  16. Van der Linden E, Pattynama PM, Heeres BC, de Jong SC, Hop WC, Kroft LJ (2009) Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations. Radiology 251:926–932

    Article  PubMed  Google Scholar 

  17. Oduber CEU, Khemlani K, Smitt JHS, Hennekam RCM, van der Horst CMAM (2010) Baseline quality of life in patients with Klippel-Trenaunay syndrome. J Plast Reconstruct Aesthet Surg 63:603–609

    Article  Google Scholar 

  18. Geirdal AØ, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K (2012) Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study. Am J Med Genet A 158A:1269–1278

    Article  PubMed  Google Scholar 

  19. Breugem CC, Merkus MP, Smitt JH, Legemate DA, van der Horst CM (2004) Quality of life in patients with vascular malformations of the lower extremity. Br J Plast Surg 57:754–763

    Article  PubMed  Google Scholar 

  20. Rautio R, Laranne J, Kähärä V, Saarinen J, Keski-Nisula L (2004) Long-term results and quality of life after endovascular treatment of venous malformations in the face and neck. Acta Radiol 45:738–745

    Article  CAS  PubMed  Google Scholar 

  21. Rautio R, Saarinen J, Laranne J, Salenius JP, Keski-Nisula L (2004) Endovascular treatment of venous malformations in extremities: results of sclerotherapy and the quality of life after treatment. Acta Radiol 45:397–403

    Article  CAS  PubMed  Google Scholar 

  22. Ware JE Jr, Harris WJ, Gandek B, Rogers BW, Reese PR (1997) MAP-R for Windows: Multitrait/multi-item scale analysis software. Health Assessment Lab, Boston

Download references

Acknowledgments

The scientific guarantor of this publication is WAW. WAW, WU and RMW declare relationships with the following companies: ab medica, Düsseldorf, Germany (lecturing, proctoring). The authors state that this work has not received any funding. WAW has significant statistical expertise. Institutional review board approval from the Ethikkommission an der Universität Regensburg was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: prospective, longitudinal study, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walter A. Wohlgemuth.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wohlgemuth, W.A., Müller-Wille, R., Teusch, V. et al. Ethanolgel sclerotherapy of venous malformations improves health-related quality-of-life in adults and children – results of a prospective study. Eur Radiol 27, 2482–2488 (2017). https://doi.org/10.1007/s00330-016-4603-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-016-4603-0

Keywords

Navigation